AVEO Pharma (AVEO) Says Partner Astellas Won't Submit Tivozani to EMA, Won't Fund Future Trials
Go back to AVEO Pharma (AVEO) Says Partner Astellas Won't Submit Tivozani to EMA, Won't Fund Future Trials| AVEO PHARMA (NASDAQ: AVEO) | Delayed: 15.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.00 | 52 Week High | $1.42 | |||
| Open | $15.00 | 52 Week Low | $0.56 | |||
| Day High | $15.00 | P/E | N/A | |||
| Day Low | $15.00 | EPS | $-2.28 | |||
| Volume | 1,468,398 | |||||
